Clinical Trial Update: Open-label Ziprasidone Study for Psychosis Treatment in Adolescents [Phase 3]

View source ↗

Summary

This open-label Phase 3 trial evaluated ziprasidone for treating psychosis-related disorders in adolescents, including schizophreniform disorder, schizoaffectiv…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder
• Major Depressive Disorder
• Psychosis
• Schizoaffective Disorder
• Schizophreniform Disorder

Drugs mentioned

• Geodon (Ziprasidone)

Snippet

Sponsor: New York State Psychiatric Institute | Conditions: Schizophreniform Disorder, Schizoaffective Disorder | Phase 3 | Status: COMPLETED | Results posted: 2017-01-13